Posts

Genentech lays off 103 as part of gRED rethink, advances with $490M breast cancer collaboration

on

Genentech executes another round of layoffs, with 3 VPs axed

on

Valneva to cut up to 15% of jobs as reduced travel hits vaccine demand

on

Takeda Restructuring: Over 600 US Layoffs Amid $1.3B Transformation Plan

on

BioNTech Shuts Down COVID Vaccine Production, Closing Sites and Cutting 1,860 Jobs

on

Click Therapeutics Lays Off 25 Employees After $50M Raise and CT-155 Commercial Restructuring

on

Takeda Terminates Denali Partnership, Returns DNL593 Dementia Asset Amid Restructuring

on

Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape

on

Evotec Announces Up to 800 Job Cuts and Four Site Closures in Horizon Reorganization Phase

on

RFK Jr. Reshuffles HHS Leadership Amid Major Agency Restructuring

on

Apple Tree files for bankruptcy as it seeks fresh funding from Russian billionaire backer

on

Novartis Announces Plans to Lay Off 550 Workers at Swiss Factory

on

Nxera Pharma to Cut 15% of Workforce in Japan and UK as Part of Restructuring Plan

on

Merck Continues Cuts: 204 Employees Laid Off in New Jersey

on

Bayer's Pharma Division Grows as Restructuring Drives Major Changes

on

Takeda Makes Pipeline Cuts and Faces Softer Q2 Sales Due to Generic Competition

on

Galapagos Winds Down Cell Therapy Business After Failed Sale, Cuts 365 Jobs and Shutters Global Sites

on

Cuts Continue as Novo Nordisk Restructuring Moves Forward

on

Novo Nordisk Ends Cell Therapy Research Amid Major Restructuring

on

Takeda to Cut 137 Staffers After Exiting Cell Therapy Research

on